Re: The death factor vs. the flake factor

Bringing up the iatrogenic illness\casualty argument doesn’t work here. No one is keeping an eye on NDs to know the ratio of negative events to number of patients seen. In NJ, there have been a number of problems with the handful of NPs, grads of accredited schools. The nature of allopathic medicine being an intervention when things have gone to far set it up for the high number of deaths, drug reactions and complications that occur.

In both fields, similar methods of researching therapies can lead to patients being the Phase IV general population that we see with conventional pharmaceutical research and marketing. Many “natural”” therapies are based on theory, ad hoc fallacy, and just plain bad research (small sample sizes, biased studies – same as conventional). One only need look at the supposed miracle of soy foods to see that this is an industry-driven revenue maker for the natural health industry.